Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desmopressin for Post-Kidney Biopsy Bleeding
NCT05467033Phase 3Recruiting
- Sponsor
- Medical University of Białystok
- Start
- Sep 2022
- Primary completion
- Aug 2026
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of desmopressin in Glomerulonephritis (GN), sponsored by Medical University of Białystok. Started Sep 2022; status: recruiting.
02
Drugs
desmopressin
03
Conditions
Glomerulonephritis (GN)
Beyond the preview
Go deeper on NCT05467033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05467033.